SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,717.67+0.34%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%
Benzinga

Maps

Maps are graphical depictions of geographic areas, showing physical features, political boundaries, and other spatial data. They are essential tools for navigation, urban planning, environmental studies, and logistics. Modern maps range from traditional paper charts to digital interactive platforms, integrating real-time data for transportation, weather, and geographic information systems (GIS).

South Park Vs. Trump (And Google & Apple): Hit Animated Show Switches Name in Nod to President’s Map Changes
South Park Vs. Trump (And Google & Apple): Hit Animated Show Switches Name in Nod to President’s Map Changes
MapQuest vs. Trump: OG of Maps Keeps Lake Ontario Name, Sees Download Surge and Stock Boost for Parent
MapQuest vs. Trump: OG of Maps Keeps Lake Ontario Name, Sees Download Surge and Stock Boost for Parent
MAPS Drops Free Psychedelic Education And Artist-Curated Playlists - Start Your Journey Here
MAPS Drops Free Psychedelic Education And Artist-Curated Playlists - Start Your Journey Here
MapQuest vs. Trump: OG of Maps Keeps Lake Ontario Name, Sees Download Surge and Stock Boost for Parent
MapQuest vs. Trump: OG of Maps Keeps Lake Ontario Name, Sees Download Surge and Stock Boost for Parent
MAPS Drops Free Psychedelic Education And Artist-Curated Playlists - Start Your Journey Here
MAPS Drops Free Psychedelic Education And Artist-Curated Playlists - Start Your Journey Here
Cannabis Industry Leaders React To Trump Victory: Expect Changes
Cannabis Industry Leaders React To Trump Victory: Expect Changes
MAPS, Eight Capital And Integrated V.C. Backs Numinus $6M Offering
MAPS, Eight Capital And Integrated V.C. Backs Numinus $6M Offering

Maps Recent News

Billionaire Mets Owner Steve Cohen Donates $5M For Psychedelics Research, But Isn't Supporting Chris Christie Yet
Billionaire Mets Owner Steve Cohen Donates $5M For Psychedelics Research, But Isn't Supporting Chris Christie Yet
In a landmark advancement for psychedelic science, the Multidisciplinary Association for Psychedelic Studies' Public Benefit Corporation (MAPS PBC) has unveiled its intent to lodge a New Drug Application (NDA) with the Fo
MDMA Assisted Therapy Approval And Commercialization Projected Within Calendar 2024 Timeline
MDMA Assisted Therapy Approval And Commercialization Projected Within Calendar 2024 Timeline
As the Psychedelic Science 2023 Conference in Denver wears on, interesting tidbits of data are emerging into the public sphere.
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study
In a prelude to what is hoped will be regulatory approval of MDMA-assisted therapy in the U.S. and Canada, Numinus Wellness Inc. (OTC: NUMIF) has taken steps to get out in front of the curve.
This Psychiatrist Says Cannabis Is A Minor-League Psychedelic & Undervalued Investment Opportunity
This Psychiatrist Says Cannabis Is A Minor-League Psychedelic & Undervalued Investment Opportunity
Cannabis is a psychedelic that belongs to the group of mind-manifesting substances, according to Dr. Julie Holland. "When you get high on cannabis, you can see your thoughts differently, and it can give you a bigger perspective on life," she said in an interview with Rena Sherbill from the Cannabis Investing Podcast.
EXCLUSIVE: MAPS To Host Major Psychedelics Event In 2023, Speakers & Details Below
EXCLUSIVE: MAPS To Host Major Psychedelics Event In 2023, Speakers & Details Below
The Multidisciplinary Association for Psychedelic Studies (MAPS) has shared details for its Psychedelic Science 2023 event taking place next June 19 to 23 in Denver, Colorado. 
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: How Are They Commercialized?
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: How Are They Commercialized?
(Part four of a four-part series)
Canada: MDMA-Assisted Therapy Trials Reviewed By Health Canada, Here's What's Happening
Canada: MDMA-Assisted Therapy Trials Reviewed By Health Canada, Here's What's Happening
Health Canada has just completed a review of all active MDMA-assisted psychotherapy trials, in response to alleged patient safety issues and research flaws. The issues had resulted in one of the two existing studies being suspended while the other allowed to proceed with some "corrective and preventive" changes.
MAPS Launches Online Course Providing 'Accurate, Evidence-based Information On Psychedelics'
MAPS Launches Online Course Providing 'Accurate, Evidence-based Information On Psychedelics'
MAPS, an NGO leading research in the psychedelics space, is launching “Psychedelic Fundamentals,” an online psychedelic education program providing "accurate, evidence-based information on psychedelics," now available for purchase on the organization's website.
Psychedelic Art Auction: Over $1.5M Raised At Christie's Curated NFT Sale For MAPS
Psychedelic Art Auction: Over $1.5M Raised At Christie's Curated NFT Sale For MAPS
Cartography of the Mind has raised over $1.5 million.
BREAKING: NFT Buyers, You Can Now Engage In Psychedelics' Legal Struggle At Christie's Auction To Support MAPS
BREAKING: NFT Buyers, You Can Now Engage In Psychedelics' Legal Struggle At Christie's Auction To Support MAPS
Christie’s, the legendary art and luxury auction house, along with Dialectic and Vine Ventures, will auction off NFT works for those interested in digital art and supporting scientific studies.
Ecstasy Research Trial Completes Enrollment, Moves Closer To Approval To Treat PTSD
Ecstasy Research Trial Completes Enrollment, Moves Closer To Approval To Treat PTSD
The non-profit Multidisciplinary Association for Psychedelics Studies (MAPS) and its subsidiary MAPS Public Benefit Corporation finished the enrollment stage for the second Phase 3 clinical trial on MDMA (MAPP2).
EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space
EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space
Any biotech investor knows how important catalysts are for the companies in the space. One FDA approval or denial can make or break the price of the stock.  In the psychedelic space, catalysts could be even more important, as the industry as a whole is still in its infancy. 
These 3 Psychedelic Stocks Will Benefit When The FDA Green-Lights MDMA (Molly, Ecstasy)
These 3 Psychedelic Stocks Will Benefit When The FDA Green-Lights MDMA (Molly, Ecstasy)
What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported positive results from a phase-3 trial testing the efficacy of MDMA-assisted therapy.
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy
UK's Top Health Agency Grants "Innovation Passport" To Psychedelic Drug MDMA In Treatment Of PTSD
UK's Top Health Agency Grants "Innovation Passport" To Psychedelic Drug MDMA In Treatment Of PTSD
The UK’s Medicines and Healthcare Products Regulatory Agency has granted an “Innovation Passport” to the drug MDMA, also known as “ecstasy” or “molly,” in the treatment of post-traumatic stress disorder.
Michigan Report: $20M In Cannabis Cash To Research PTSD Among Veterans And Using Weed Does Not Disqualify Unemployment Eligibility
Michigan Report: $20M In Cannabis Cash To Research PTSD Among Veterans And Using Weed Does Not Disqualify Unemployment Eligibility
The state of Michigan is funding two major medical cannabis research projects to the tune of $20 million with tax revenue from the state’s recreational marijuana program, announced Michigan’s Marijuana Regulatory Agency (MRA).
Psychedelic Therapy Execs On Latest Developments In Space, Remaining Hurdles
Psychedelic Therapy Execs On Latest Developments In Space, Remaining Hurdles
Assisted psychedelic treatment executives came together at the two-day, virtual Benzinga Global Small Cap Conference on Thursday to discuss recent lab developments and the significant hurdles ahead in mental health and addiction treatment.
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved